Product Images Montelukast Sodium

This is a description of a medication tablet with the NDC code 69844-074-01. The tablet is chewable and contains 4.2 mg of Montelukast Sodium manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India. It is intended for pediatric patients aged 2 to 5 years and usual dosage can be found in the Monograph. The medication may contain phenylalanine and should be stored at 25°C (77°F) with permitted excursions to 10-30°C (59° to 86°F). The medicine needs to be kept away from moisture and light and in the unvarnished area of its original package to maintain its effectiveness. The label warns to keep it out of the reach of children. The revision date mentioned on the label is 04/2022.*

Montelukast Sodium Chewable Tablets USP are indicated for pediatric patients between 6 to 14 years of age. The medicine comes in a package of 30 tablets, each containing 5.2mg Montelukast Sodium equivalent to 5 mg Montelukast. Aspartame, which contains phenylalanine (0.47 mg per 5mg chewable tablet) is not suitable for phenylketonuria patients. The recommended dosage is available in the package insert. Store the tablets in the original package in a dry place, protected from light, at temperatures between 15°C and 30°C. Graviti Pharmaceuticals, India, manufactures these tablets for Graviti Pharmaceuticals Inc., USA. Keep this and all drugs away from children. This information was last revised in April 2022.*